Variation in genes coding for AMP-activated protein kinase (AMPK) and breast cancer risk in the European Prospective Investigation on Cancer (EPIC)

Breast Cancer Research and Treatment

Volumn 127, Issue 3, 2011, Pages 761-767

  Campa, Daniele ^a   Claus, Rainer ^a   Dostal, Lucie ^a   Stein, Angelika ^a   Chang Claude, Jenny ^a   Meidtner, Karina ^b   Boeing, Heiner ^b   Olsen, Anja ^c   Tjønneland, Anne ^c   Overvad, Kim ^d,e   Rodríguez, Laudina ^f   Bonet, Catalina ^g   Sánchez, Maria José ^h,i   Amiano, Pilar ^i,j   Huerta, José María ^i,k   Barricarte, Aurelio ^i,l   Khaw, Kay Tee ^m   Wareham, Nicholas ⁿ   Travis, Ruth C ^o   Allen, Naomi E ^o   Trichopoulou, Antonia ^p,q   Bamia, Christina ^q   Benetou, Vassiliki ^q   Palli, Domenico ^r   Agnoli, Claudia ^s   Panico, Salvatore ^t   Tumino, Rosario ^u   Sacerdote, Carlotta ^v,w   Van Kranen, Henk ^x   Bas Bueno De Mesquita, H ^x   Peeters, Petra H M ^y   Van Gils, Carla H ^y   Lenner, Per ^z   Sund, Malin ^z   Lund, Eiliv ^aa   Gram, Inger Torhild ^aa   Rinaldi, Sabina ^ab   Chajes, Veronique ^ab   Romieu, Isabelle ^ab   Engel, Pierre ^ac   Boutron Ruault, Marie Christine ^ac   Clavel Chapelon, Françoise ^ac   Siddiq, Afshan ^ad   Riboli, Elio ^ad   Canzian, Federico ^a   Kaaks, Rudolf ^a   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^c INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

^e AARHUS UNIVERSITY   (Denmark)

^f Health and Health Care Services Council   (Spain)

^g CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^h ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

ⁱ CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^j BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^k Murcia Regional Health Authority   (Spain)

^l INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^m UNIVERSITY OF CAMBRIDGE   (United Kingdom)

ⁿ MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^o UNIVERSITY OF OXFORD   (United Kingdom)

^p HELLENIC HEALTH FOUNDATION   (Greece)

^q UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^r CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^s NATIONAL CANCER INSTITUTE   (Italy)

^t UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^u CIVILE M P AREZZO HOSPITAL   (Italy)

^v Center for Cancer Prevention CPO Piemonte   (Italy)

^w Human Genetics Foundation   (Italy)

^x NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^y UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^z UMEÅ UNIVERSITY   (Sweden)

^aa UNIVERSITY OF TROMSØ   (Norway)

^ab INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^ac HÔPITAL PAUL BROUSSE   (France)

^ad IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

AMP activated protein kinase; Body mass index; Breast cancer; Cancer susceptibility

Indexed keywords

ADENYLATE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PROTEIN SERINE THREONINE KINASE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY FAT; BODY MASS; BREAST CANCER; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FATTY ACID SYNTHESIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HETEROZYGOTE DETECTION; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; ONCOGENE; PRIORITY JOURNAL; PRKAA1 GENE; PRKAA2 GENE; PRKAB1 GENE; PRKAB2 GENE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AMP-ACTIVATED PROTEIN KINASES; BODY MASS INDEX; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 79958264925     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1269-1     Document Type: Article

References (40)

1. LS Augustin L Dal Maso C La Vecchia M Parpinel E Negri S Vaccarella CW Kendall DJ Jenkins S Francesch 2001 Dietary glycemic index and glycemic load, and breast cancer risk: a case-control study Ann Oncol 12 11 1533 1538 11822751 10.1023/A:1013176129380 1:STN:280:DC%2BD38%2FptlGisA%3D%3D (Pubitemid 34065881)
2. F Bianchini R Kaaks H Vainio 2002 Overweight, obesity, and cancer risk Lancet Oncol 3 9 565 574 S1470204502008495[pii] 12217794 10.1016/S1470-2045(02) 00849-5 (Pubitemid 34993644)
3. R Kaaks 1996 Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control 7 6 605 625 8932921 10.1007/BF00051703 1:STN:280:DyaK2s%2Fos1yqsA%3D%3D (Pubitemid 26377730)
4. R Kaaks A Lukanova 2001 Energy balance and cancer: the role of insulin and insulin-like growth factor-I Proc Nutr Soc 60 1 91 106 S002966510100012X[pii] 11310428 10.1079/PNS200070 1:CAS:528:DC%2BD3MXitlKmt7g%3D (Pubitemid 32183103)
5. P Muti T Quattrin BJ Grant V Krogh A Micheli HJ Schunemann M Ram JL Freudenheim S Sieri M Trevisan F Berrino 2002 Fasting glucose is a risk factor for breast cancer: a prospective study Cancer Epidemiol Biomarkers Prev 11 11 1361 1368 12433712 1:CAS:528:DC%2BD38XpsVyksrg%3D (Pubitemid 35340370)
6. BE Kemp D Stapleton DJ Campbell ZP Chen S Murthy M Walter A Gupta JJ Adams F Katsis B van Denderen IG Jennings T Iseli BJ Michell LA Witters 2003 AMP-activated protein kinase, super metabolic regulator Biochem Soc Trans 31 Pt 1 162 168 12546677 1:CAS:528:DC%2BD3sXptF2ksg%3D%3D (Pubitemid 36241420)
7. D Carling 2005 AMP-activated protein kinase: balancing the scales Biochimie 87 1 87 91 15733742 10.1016/j.biochi.2004.10.017 1:CAS:528: DC%2BD2MXhslCntLs%3D (Pubitemid 40298770)
8. DG Hardie 2007 AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy Nat Rev Mol Cell Biol 8 10 774 785 17712357 10.1038/nrm2249 1:CAS:528:DC%2BD2sXhtVKmt7vP (Pubitemid 47462132)
9. DG Hardie JW Scott DA Pan ER Hudson 2003 Management of cellular energy by the AMP-activated protein kinase system FEBS Lett 546 1 113 120 12829246 10.1016/S0014-5793(03)00560-X 1:CAS:528:DC%2BD3sXkvVKjs7Y%3D (Pubitemid 36782291)
10. MC Towler DG Hardie 2007 AMP-activated protein kinase in metabolic control and insulin signaling Circ Res 100 3 328 341 17307971 10.1161/01.RES.0000256090.42690.05 1:CAS:528:DC%2BD2sXhsF2kur0%3D
11. DG Hardie 1992 Regulation of fatty acid and cholesterol metabolism by the AMP-activated protein kinase Biochim Biophys Acta 1123 3 231 238 1536860 1:CAS:528:DyaK38Xht1GgtrY%3D
12. D Campa J McKay O Sinilnikova A Husing U Vogel RD Hansen K Overvad PM Witt F Clavel-Chapelon MC Boutron-Ruault V Chajes S Rohrmann J Chang-Claude H Boeing E Fisher A Trichopoulou D Trichopoulos D Palli A Villarini C Sacerdote A Mattiello R Tumino PH Peeters CH van Gils H Bas Bueno-de-Mesquita E Lund MD Chirlaque N Sala LR Suarez A Barricarte M Dorronsoro MJ Sanchez P Lenner G Hallmans K Tsilidis S Bingham KT Khaw V Gallo T Norat E Riboli S Rinaldi G Lenoir SV Tavtigian F Canzian R Kaaks 2009 Genetic variation in genes of the fatty acid synthesis pathway and breast cancer risk Breast Cancer Res Treat 118 565 574 19252981 10.1007/s10549-009-0347-8 1:CAS:528:DC%2BD1MXhtlyls7%2FO
13. JA Menendez R Lupu 2007 Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis Nat Rev Cancer 7 10 763 777 nrc2222[pii]10.1038/nrc2222 17882277 10.1038/nrc2222 1:CAS:528:DC%2BD2sXhtVOnsr3P (Pubitemid 47469806)
14. JA Menendez R Colomer R Lupu 2005 Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids? Med Hypotheses 64 2 342 349 S0306-9877(04)00455-4[pii]10.1016/j.mehy.2004.07.022 15607569 10.1016/j.mehy.2004.07.022 1:CAS:528:DC%2BD2cXhtVyrsrbN (Pubitemid 40028283)
15. S Rossi W Ou D Tang N Bhattacharya AP Dei Tos JA Fletcher M Loda 2006 Gastrointestinal stromal tumours overexpress fatty acid synthase J Pathol 209 3 369 375 16583360 10.1002/path.1983 1:CAS:528:DC%2BD28XnslOjt74%3D (Pubitemid 43997746)
16. T Takahiro K Shinichi S Toshimitsu 2003 Expression of fatty acid synthase as a prognostic indicator in soft tissue sarcomas Clin Cancer Res 9 6 2204 2212 12796387 1:CAS:528:DC%2BD3sXksVWqu7k%3D (Pubitemid 36687644)
17. YA Yang PJ Morin WF Han T Chen DM Bornman EW Gabrielson ES Pizer 2003 Regulation of fatty acid synthase expression in breast cancer by sterol regulatory element binding protein-1c Exp Cell Res 282 2 132 137 S001448270200023X[pii] 12531699 10.1016/S0014-4827(02)00023-X 1:CAS:528:DC%2BD3sXjtFCnug%3D%3D (Pubitemid 36259906)
18. MP Cleary ME Grossmann 2009 Minireview: obesity and breast cancer: the estrogen connection Endocrinology 150 6 2537 2542 19372199 10.1210/en.2009-0070 1:CAS:528:DC%2BD1MXmvVCqt7Y%3D
19. MP Cleary ME Grossmann A Ray 2010 Effect of obesity on breast cancer development Vet Pathol 47 2 202 213 20124008 10.1177/0300985809357753 1:CAS:528:DC%2BC3cXkvFOhur8%3D
20. CA Gonzalez E Riboli 2010 Diet and cancer prevention: contributions from the European Prospective Investigation into Cancer and Nutrition (EPIC) study Eur J Cancer 46 14 2555 2562 20843485 10.1016/j.ejca.2010.07.025
21. DP Rose L Vona-Davis 2010 Interaction between menopausal status and obesity in affecting breast cancer risk Maturitas 66 1 33 38 20181446 10.1016/j.maturitas.2010.01.019
22. S Sieri V Krogh P Ferrari F Berrino V Pala AC Thiebaut A Tjonneland A Olsen K Overvad MU Jakobsen F Clavel-Chapelon V Chajes MC Boutron-Ruault R Kaaks J Linseisen H Boeing U Nothlings A Trichopoulou A Naska P Lagiou S Panico D Palli P Vineis R Tumino E Lund M Kumle G Skeie CA Gonzalez E Ardanaz P Amiano MJ Tormo C Martinez-Garcia JR Quiros G Berglund B Gullberg G Hallmans P Lenner HB Bueno-de-Mesquita FJ van Duijnhoven PH Peeters CH van Gils TJ Key FL Crowe S Bingham KT Khaw S Rinaldi N Slimani M Jenab T Norat E Riboli 2008 Dietary fat and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition Am J Clin Nutr 88 5 1304 1312 18996867 1:CAS:528:DC%2BD1cXhtlOqu73F
23. GR Hudes 2007 mTOR as a target for therapy of renal cancer Clin Adv Hematol Oncol 5 10 772 774 17998894 (Pubitemid 351720395)
24. B Rubio-Viqueira M Hidalgo 2006 Targeting mTOR for cancer treatment Curr Opin Investig Drugs 7 6 501 512 16784020 1:CAS:528:DC%2BD28XmsFyqtb0%3D (Pubitemid 43891028)
25. H Motoshima BJ Goldstein M Igata E Araki 2006 AMPK and cell proliferation-AMPK as a therapeutic target for atherosclerosis and cancer J Physiol 574 Pt 1 63 71 16613876 10.1113/jphysiol.2006.108324 1:CAS:528:DC%2BD28XnsVyju7o%3D (Pubitemid 43905797)
26. M Igata H Motoshima K Tsuruzoe K Kojima T Matsumura T Kondo T Taguchi K Nakamaru M Yano D Kukidome K Matsumoto T Toyonaga T Asano T Nishikawa E Araki 2005 Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression Circ Res 97 8 837 844 16151020 10.1161/01.RES.0000185823.73556.06 1:CAS:528:DC%2BD2MXhtVymt7nL (Pubitemid 41447135)
27. RG Jones DR Plas S Kubek M Buzzai J Mu Y Xu MJ Birnbaum CB Thompson 2005 AMP-activated protein kinase induces a p53-dependent metabolic checkpoint Mol Cell 18 3 283 293 15866171 10.1016/j.molcel.2005.03.027 1:CAS:528: DC%2BD2MXkt1Cgtbw%3D (Pubitemid 41350534)
28. K Imamura T Ogura A Kishimoto M Kaminishi H Esumi 2001 Cell cycle regulation via p53 phosphorylation by a 5'-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line Biochem Biophys Res Commun 287 2 562 567 11554766 10.1006/bbrc.2001.5627 1:CAS:528:DC%2BD3MXms12qsLk%3D (Pubitemid 32917636)
29. E Riboli KJ Hunt N Slimani P Ferrari T Norat M Fahey UR Charrondiere B Hemon C Casagrande J Vignat K Overvad A Tjonneland F Clavel-Chapelon A Thiebaut J Wahrendorf H Boeing D Trichopoulos A Trichopoulou P Vineis D Palli HB Bueno-De-Mesquita PH Peeters E Lund D Engeset CA Gonzalez A Barricarte G Berglund G Hallmans NE Day TJ Key R Kaaks R Saracci 2002 European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection Public Health Nutr 5 6B 1113 1124 10.1079/ PHN2002394S1368980002001350[pii] 12639222 10.1079/PHN2002394 1:STN:280:DC%2BD3s7is1Ohsw%3D%3D (Pubitemid 36313608)
30. CS Carlson MA Eberle MJ Rieder Q Yi L Kruglyak DA Nickerson 2004 Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium Am J Hum Genet 74 1 106 120 14681826 10.1086/381000 1:CAS:528:DC%2BD2cXlvVOrsA%3D%3D (Pubitemid 38085242)
31. PI de Bakker R Yelensky I Pe'er SB Gabriel MJ Daly D Altshuler 2005 Efficiency and power in genetic association studies Nat Genet 37 11 1217 1223 ng1669[pii]10.1038/ng1669 16244653 10.1038/ng1669 (Pubitemid 41568704)
32. C Jurinke D van den Boom CR Cantor H Koster 2001 Automated genotyping using the DNA MassArray technology Methods Mol Biol 170 103 116 11357675 1:CAS:528:DC%2BD3MXjtVeruro%3D (Clifton NJ)
33. J Little JP Higgins JP Ioannidis D Moher F Gagnon E von Elm MJ Khoury B Cohen G Davey-Smith J Grimshaw P Scheet M Gwinn RE Williamson GY Zou K Hutchings CY Johnson V Tait M Wiens J Golding C van Duijn J McLaughlin A Paterson G Wells I Fortier M Freedman M Zecevic R King C Infante-Rivard A Stewart N Birkett 2009 STrengthening the REporting of Genetic Association studies (STREGA)-an extension of the STROBE statement Eur J Clin Invest 39 4 247 266 19297801 10.1111/j.1365-2362.2009.02125.x
34. DG Hardie 2005 New roles for the LKB1- >AMPK pathway Curr Opin Cell Biol 17 2 167 173 15780593 10.1016/j.ceb.2005.01.006 1:CAS:528: DC%2BD2MXisVCqtb0%3D (Pubitemid 40380940)
35. Z Luo AK Saha X Xiang NB Ruderman 2005 AMPK, the metabolic syndrome and cancer Trends Pharmacol Sci 26 2 69 76 15681023 10.1016/j.tips.2004.12.011 1:CAS:528:DC%2BD2MXoslahug%3D%3D (Pubitemid 40170168)
36. KA Brown NI Hunger M Docanto ER Simpson 2010 Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase Breast Cancer Res Treat 123 2 591 596 20300828 10.1007/s10549-010-0834-y 1:CAS:528:DC%2BC3cXpvFegur4%3D
37. AM Gonzalez-Angulo F Meric-Bernstam 2010 Metformin: a therapeutic opportunity in breast cancer Clin Cancer Res 16 6 1695 1700 20215559 10.1158/1078-0432.CCR-09-1805 1:CAS:528:DC%2BC3cXjtFyhtLk%3D
38. N Fortunati MG Catalano G Boccuzzi R Frairia 2010 Sex Hormone-Binding Globulin (SHBG), estradiol and breast cancer Mol Cell Endocrinol 316 1 86 92 19770023 10.1016/j.mce.2009.09.012 1:CAS:528:DC%2BD1MXhs1WgsbrM
39. DJ Jerry KA Dunphy MJ Hagen 2010 Estrogens, regulation of p53 and breast cancer risk: a balancing act Cell Mol Life Sci 67 1017 1023 20238478 10.1007/s00018-009-0244-7 1:CAS:528:DC%2BC3cXivFaktLs%3D
40. A Mantovani F Marchesi C Porta A Sica P Allavena 2007 Inflammation and cancer: breast cancer as a prototype Breast (Edinburgh, Scotland) 16 Suppl 2 S27 S33